跳至主要内容
临床试验/NCT05545787
NCT05545787
已完成
不适用

A Prospective, Randomized, Non-inferiority Study to Compare Efficacy and Safety of Cold Snare Endoscopic Mucosal Resection and Hot Snare Endoscopic Mucosal Resection in Treatment for 10-19 mm Non-pedunculated Colorectal Polyps

Qingwei Jiang29 个研究点 分布在 1 个国家目标入组 216 人2022年10月14日

概览

阶段
不适用
干预措施
Cold snare endoscopic mucosal resection
疾病 / 适应症
Colorectal Polyp
发起方
Qingwei Jiang
入组人数
216
试验地点
29
主要终点
Complete resection rate
状态
已完成
最后更新
昨天

概览

简要总结

This is a prospective, randomized, open-label, non-inferiority, multiple-center trial. Outpatients who are scheduled to undergo colonoscopy and found eligible polyps will be randomized to receive either cold snare endoscopic mucosal resection (CS-EMR) or hot snare endoscopic mucosal resection (HS-EMR). This study aims to compare the efficacy and safety of CS-EMR or HS-EMR for the resection of non-pedunculated colorectal polyps sized 10-19mm.

注册库
clinicaltrials.gov
开始日期
2022年10月14日
结束日期
2026年4月15日
最后更新
昨天
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Qingwei Jiang
责任方
Sponsor Investigator
主要研究者

Qingwei Jiang

attending physician

Peking Union Medical College Hospital

入排标准

入选标准

  • 18-80 years of age;
  • undergo colonoscopy in the Digestive Endoscopy Center of Peking Union Medical College Hospital, Beijing Tsinghua Changgung Hospital or Seventh Medical Center, General Hospital of the Chinese People's Liberation Army;
  • volunteer to participate in this study and sign informed consent;
  • at least one polyp sized 10-19 mm (Paris classification Is or IIa) by colonoscopy.

排除标准

  • American Society of Anesthesiologists (ASA) status class 3 or above;
  • poor bowel preparation (Boston bowel preparation scale \< 6 points);
  • known or endoscopic features indicating the submucous infiltration or malignancy;
  • oral anti-coagulants, or antiplatelet agents, or known blood coagulation disorders, or bleeding tendency (platelets\<50000 cells/mm3 or INR\>1.5);
  • a history of colorectal resection;
  • emergency colonoscopy (hemodynamic instability and/or continued active gastrointestinal bleeding and/or requiring intensive care patients);
  • inflammatory bowel disease, familial polyposis, and colorectal cancer;
  • pregnancy or lactation;
  • severe cardiopulmonary dysfunction, liver cirrhosis, chronic kidney disease, other malignant tumors, or severe infectious diseases.

研究组 & 干预措施

Cold snare endoscopic mucosal resection (CS-EMR)

Eligible colorectal polyps sized 10-19mm will be resected by CS-EMR

干预措施: Cold snare endoscopic mucosal resection

Hot snare endoscopic mucosal resection (HS-EMR)

Eligible colorectal polyps sized 10-19mm will be resected by HS-EMR

干预措施: Hot snare endoscopic mucosal resection

结局指标

主要结局

Complete resection rate

时间窗: Within 14 days

The resection is considered histologically complete if the lateral margins of the resected polyps are surrounded by normal tissue and the vertical margin is free of neoplasia tissue. If en-bloc resection is not achieved, 5 biopsies (4 biopsies obtained in a 4-quadrant fashion from the polypectomy site margins; 1 biopsy from the base) are applied to evaluate histological completeness of resection.

次要结局

  • En-bloc resection rate(Within 1 day)
  • Intraprocedural bleeding(Within 1 day)
  • Intraprocedural perforation(Within 1 day)
  • Delayed bleeding(Within 14 days)
  • Delayed perforation(Within 14 days)
  • Number of clips used(Within 1 day)
  • Total cost(Within 1 day)
  • Resection time(Within 1 day)

研究点 (29)

Loading locations...

相似试验